trending Market Intelligence /marketintelligence/en/news-insights/trending/b89ORDxFhwSLkh9OE5E3BA2 content esgSubNav
In This List

Orchard Therapeutics completes $110M financing, appoints director

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Orchard Therapeutics completes $110M financing, appoints director

Orchard Therapeutics Ltd completed an oversubscribed $110 million series B financing.

The company said Baillie Gifford and ORI Capital co-led the financing.

In connection with the financing, Simone Song, senior partner at ORI Capital, was appointed to Orchard's board of directors.

Orchard said it plans to use the proceeds to move its pipeline forward, including the launch of its gene therapy OTL-101.